Management of vomiting associated with cytotoxic therapy.
Recent advances in the understanding of emesis have resulted in the development of serotonin 3 receptor antagonists. The careful use of these drugs and other conventional antiemetic agents can substantially reduce the nausea and vomiting associated with chemotherapy and improve the quality of life for cancer patients undergoing treatment.